Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)

Published on October 21, 2021

Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer.

Continue reading on website
Other news

Apellis (APLS) Gets CHMP Nod for Rare Blood Disorder Drug (Revised)

October 21, 2021
The CHMP gives a positive opinion on and recommends granting marketing authorization to Apellis' (APLS) Aspaveli for the treatment of adults with paroxysmal nocturnal hemoglobinuria.

Having More than Once Source of Income Can Make You Rich. Here's How to Make it Happen

October 21, 2021
Millionaires have hit the nail on the head: They have more than one income stream. If it's the secret to success, let's find out how to make it work for...